1369 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Shah
    Shah
  4. Sauter
    Sauter
  5. Palomba
    Palomba
  6. Goldberg
    Goldberg
  7. Halton
    Halton
  8. Brentjens
    Brentjens
  9. Chen
    Chen
  10. Moskowitz
    Moskowitz

Groups

  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)
  7. Hematologic Malignancies, Division of (327)
  8. Solid Tumor Oncology Division (324)
  9. Population Sciences Research Program (261)
  10. Biostatistics Service (257)
  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (694)
  2. Journal Article (538)
  3. Review (51)
  4. Book Section (36)
  5. Editorial (16)
  6. Research Letter (14)
  7. Miscellaneous (10)
  8. Conference Paper (4)
  9. Correspondence (4)
  10. Book Whole (1)
  11. Guidelines (1)
Groups
  1. Advanced Practice Providers (1369)
  2. Nursing (1108)
  3. Department of Medicine (653)
  4. Survivorship Research (513)
  5. Center for Hematologic Malignancies (339)
  6. Epidemiology and Biostatistics (328)

More Groups

People
  1. Sergio Giralt (98)
  2. Miguel-Angel Perales (77)
  3. Gunjan Shah (68)
  4. Sean Devlin (68)
  5. Craig Sauter (63)
  6. Maria Palomba (61)

More People

Years
  1. 2025 (29)
  2. 2024 (103)
  3. 2023 (92)
  4. 2022 (114)
  5. 2021 (101)
  6. 2020 (101)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Oncology Nursing Forum (117)
  3. Blood (114)
  4. Biology of Blood and Marrow Transplantation (59)
  5. Clinical Journal of Oncology Nursing (47)
  6. Annals of Surgical Oncology (36)

More Publications

Publishers
  1. American Society of Clinical Oncology (192)
  2. Elsevier Inc. (190)
  3. Oncology Nursing Society (ONS) (169)
  4. American Society of Hematology (121)
  5. Lippincott Williams & Wilkins (91)
  6. Springer (70)

More Publishers

Results (1369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Journal Article

    Ginsberg, B. A.; Gallardo, H. F.; Rasalan, T. S.; Adamow, M.; Mu, Z.; Tandon, S.; Bewkes, B. B.; Roman, R. A.; Chapman, P. B.; Schwartz, G. K.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Postreplication gaps at UV lesions are signals for checkpoint activation
    Journal Article

    Callegari, A. J.; Clark, E.; Pneuman, A.; Kelly, T. J.
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save
  • A "no-wash" albumin-dextran dilution strategy for cord blood (CB) thaw is associated with a high rate of engraftment and a low incidence of serious infusion reactions
    Meeting Abstract

    Rice, R. D.; Abboud, M.; Hawke, R. M.; Schaible, A. M.; Heller, G.; Scaradavou, A.; Barker, J. N.
    Biology of Blood and Marrow Transplantation (2009)

    Fulltext@MSK | Save
  • A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors
    Meeting Abstract

    Schwartz, G. K.; Robertson, S.; Shen, A.; Wang, E.; Pace, L.; Dials, H.; Mendelson, D.; Shannon, P.; Gordon, M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)
    Meeting Abstract

    Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up
    Meeting Abstract

    Rudloff, U.; Brogi, E.; McCormick, B.; Brockway, J. P.; Goldberg, J. I.; Wynveen, C. A.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pancyclin-dependentkinase (CDK) inhibitor flavopiridol
    Meeting Abstract

    Dickson, M. A.; Carvajal, R. D.; Shah, M.; Tse, A. N.; Dials, H.; Cane, L. M.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of patients with multiple myeloma treated with autologous stem cell transplantation in the era of novel therapies
    Meeting Abstract

    Hassoun, H.; Landau, H.; Surti, C.; Adel, N. G.; Jia, X. Y.; Riedel, E. R.; Manisha, B.; Comenzo, R.; Lesokhin, A.; Chung, D. J.; more...
    Blood (2009)

    Fulltext@MSK | Save